Showing results (51-60 of 554) with videos related to
Sort By:
Pageof 56
Idrugs : the Investigational Drugs Journal|December 15, 2010
LX-1031, a tryptophan 5-hydroxylase inhibitor that reduces 5-HT levels for the potential treatment of irritable bowel syndromeMichael CamilleriThe American Journal of Gastroenterology|March 6, 2012
Editorial: fecal granins in IBS: cause or indicator of intestinal or colonic irritation?Michael CamilleriBritish Journal of Pharmacology|March 24, 2004
Treating irritable bowel syndrome: overview, perspective and future therapiesMichael CamilleriPharmacogenomics|July 15, 2005
Pharmacogenomics and functional gastrointestinal disordersMichael CamilleriThe American Journal of Gastroenterology|March 19, 2009
Editorial: is adequate relief fatally flawed or adequate as an end point in irritable bowel syndrome?Michael CamilleriCurrent Opinion in Endocrinology, Diabetes, and Obesity|January 1, 2009
Serotonin in the gastrointestinal tractMichael CamilleriThe Journal of Clinical Investigation|October 3, 2013
Pharmacological agents currently in clinical trials for disorders in neurogastroenterologyMichael CamilleriClinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|April 13, 2026
IBS Clinical Care Gaps and the Potential of Future Therapeutics based on Peripheral Visceral Afferent ModulationMichael CamilleriNeurogastroenterology and Motility|August 19, 2020
Irritable Bowel Syndrome: Straightening the road from the Rome criteriaMichael CamilleriThe American Journal of Gastroenterology|October 31, 2024
When and What to Test for Diarrhea: Focus on Stool TestingMichael CamilleriPageof 56